SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-22-000113
Filing Date
2022-04-07
Accepted
2022-04-07 09:01:14
Documents
13
Period of Report
2022-04-06

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF APRIL 2022 bellushealth6kmpm.htm 6-K 5259
2 NOTICE OF THE MEETING exhibit99-1.htm EX-99.1 9542
3 MANAGEMENT INFORMATION CIRCULAR exhibit99-2.htm EX-99.2 665238
4 FORM OF PROXY exhibit99-3.htm EX-99.3 929
5 VIRTUAL GUIDE exhibit99-4.htm EX-99.4 642
6 NOTICE OF AVAILABILITY exhibit99-5.htm EX-99.5 943
7 exhibit99-3x1x1.jpg GRAPHIC 470606
8 exhibit99-3x2x1.jpg GRAPHIC 362164
9 exhibit99-4x1x1.jpg GRAPHIC 395250
10 exhibit99-5x1x1.jpg GRAPHIC 464423
11 exhibit99-5x2x1.jpg GRAPHIC 166012
12 image_001.jpg GRAPHIC 5061
13 image_002.jpg GRAPHIC 50482
  Complete submission text file 0001176256-22-000113.txt   3320607
Mailing Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7
Business Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7 450-680-4500
BELLUS Health Inc. (Filer) CIK: 0001259942 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39034 | Film No.: 22812434
SIC: 2834 Pharmaceutical Preparations